Assetmark Inc. boosted its position in shares of Rentokil Initial PLC (NYSE:RTO - Free Report) by 29.0% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 837,035 shares of the company's stock after buying an additional 188,190 shares during the quarter. Assetmark Inc. owned 0.17% of Rentokil Initial worth $26,350,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also bought and sold shares of the company. Caitong International Asset Management Co. Ltd raised its holdings in shares of Rentokil Initial by 222.2% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,163 shares of the company's stock worth $34,000 after buying an additional 802 shares during the period. GAMMA Investing LLC grew its position in Rentokil Initial by 76.5% in the 4th quarter. GAMMA Investing LLC now owns 1,232 shares of the company's stock valued at $36,000 after acquiring an additional 534 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Rentokil Initial in the 4th quarter valued at $39,000. V Square Quantitative Management LLC increased its stake in Rentokil Initial by 84.5% in the first quarter. V Square Quantitative Management LLC now owns 1,395 shares of the company's stock worth $44,000 after purchasing an additional 639 shares during the period. Finally, IFP Advisors Inc increased its stake in Rentokil Initial by 53.8% in the third quarter. IFP Advisors Inc now owns 1,972 shares of the company's stock worth $50,000 after purchasing an additional 690 shares during the period. Institutional investors own 9.91% of the company's stock.
Analysts Set New Price Targets
RTO has been the topic of a number of research analyst reports. Wall Street Zen upgraded shares of Rentokil Initial from a "hold" rating to a "buy" rating in a report on Sunday, July 12th. The Goldman Sachs Group upgraded shares of Rentokil Initial from a "neutral" rating to a "buy" rating in a report on Monday, July 6th. Weiss Ratings reissued a "hold (c)" rating on shares of Rentokil Initial in a research report on Wednesday, June 24th. Finally, Zacks Research cut shares of Rentokil Initial from a "hold" rating to a "strong sell" rating in a research report on Monday, June 15th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $34.50.
Get Our Latest Report on Rentokil Initial
Rentokil Initial Stock Up 0.0%
Shares of RTO stock opened at $30.43 on Friday. The stock's fifty day moving average price is $30.21 and its 200 day moving average price is $31.37. Rentokil Initial PLC has a 1-year low of $22.77 and a 1-year high of $34.67. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.07 and a current ratio of 1.16.
Rentokil Initial Company Profile
(
Free Report)
Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.
Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.
See Also
Want to see what other hedge funds are holding RTO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rentokil Initial PLC (NYSE:RTO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.